Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer
Cancer Detection and Prevention · 2009-01 · 32 (4) · 308-313
DOI: 10.1016/j.cdp.2008.12.001 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Detection and Prevention, 2009-01. Verfasst von Yaser Atlasi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, P.O. Box 14115-175 Tehran, Iran. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Survivin, an inhibitor of apoptosis protein (IAP), has been regarded as a valuable tumor marker for diagnosis and prognosis of bladder cancer. Recently, three splice variants of the gene with different anti-apoptotic activities have been reported. However, there is no data on the expression and potential causative roles of these transcripts in bladder cancer. Here, we have investigated the expression pattern of survivin and two of its splice variants, survivin-DeltaEx3 and survivin-2B, in malignant versus non-malignant bladder tissues. METHODS: We used semi-quantitative RT-PCR analysis to examine the expression of survivin variants in 30 transitional cell carcinoma, 19 matched non-tumor, and 9 apparently healthy control tissue samples of the bladder. DNA sequencing was used to confirm the identity of amplified fragments. RESULTS: For all examined samples, survivin was the predominant transcript, being present in 83% of tumor and 25% of non-tumor bladder tissue samples, and survivin-2B was the least detected isoform. The expression levels of survivin and survivin-DeltaEx3 was significantly higher in neoplastic compared to non-neoplastic tissues (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, P.O. Box 14115-175 Tehran, Iran.
Zitieren
APA
Atlasi, Y., Mowla, S. J., & Ziaee, S. A. (2009). Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer. Cancer Detection and Prevention, 32(4), 308-313. https://doi.org/10.1016/j.cdp.2008.12.001
Vancouver
Atlasi Y, Mowla SJ, Ziaee SA. Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer. Cancer Detection and Prevention. 2009;32(4):308-313. doi:10.1016/j.cdp.2008.12.001
BibTeX
@article{Atlasi2009,
author = {Atlasi, Yaser and Mowla, Seyed Javad and Ziaee, Seyed Amir-Mohsen},
title = {Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer},
journal = {Cancer Detection and Prevention},
year = {2009},
volume = {32},
number = {4},
pages = {308--313},
doi = {10.1016/j.cdp.2008.12.001}
}
EUVIMED